Skip to main content
rss feedemail usour twitterour facebook page linkdin youtubeinstagram
Medical & Scientific Advisory Board
Professor Corrina McMahon
Professor Corrina McMahon
Professor Baba Inusa
Professor Baba Inusa
Dr Noémi Roy
Dr Noémi Roy

Dr Noémi Roy is a consultant haematologist at the University of Oxford Hospitals NHS Foundation Trust.  She trained in medicine in Edinburgh and carried out her haematology training in London and Oxford. Her main interests are haemoglobinopathies and rare inherited anaemias, and in particular the genetic investigation of inherited anaemias, including whole genome sequencing.  She is also involved in investigating the management of iron deficiency in diverse patient groups. She is dedicated to using patients’ views to guide how research in conducted in haematology and coordinating best practice care in red cell disorders at the European level. Noémi leads quality of life studies in sickle cell disease as well as novel ways of improving compliance, patient understanding and patient pathways for high quality care.

Dr Raffaele Renella MD DPhil (Oxon) FRCPCH

 

Consultant in Pediatric Hematology Oncology, Lausanne University Hospital (CHUV), Switzerland Head, Pediatric Hematology Oncology Research Laboratory, Faculty of Biology & Medicine, University of Lausanne (UNIL) www.unil.ch/lhop Privat-Docent & Maitre d’enseignement et de recherche clinique (Senior Lecturer), University of
Lausanne (UNIL)

  • Medical school, University of Geneva (Switzerland)
  • Clinical training in Pediatrics (Lausanne, Switzerland) and in Pediatric Hematology/Immunology/Stem Cell Transplantation (Necker-Enfants Malades Hospital, Paris, France).
  • Scientific training as Lord Florey – Berrow Scholar at the MRC Molecular Hematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford and Honorary Clinical Specialist Registrar at The NHS/John Radcliffe Hospital (UK)
  • Fellowship and then Attending Physician/Instructor Pediatric Hematology/Oncology/Stem Cell Transplantation at Boston Children’s Hospital, Dana Farber Cancer Institute, Harvard Medical School in Boston (USA)
  • Post-doctoral research, laboratory of D.A. Williams, Boston Children’s Hospital on gene-therapy for the hemoglobinopathies (USA)
OUR MISSION

Our Mission is to engage in a united, unique and strong voice for Sickle Cell patients, family members, carers, and all national patient organisations of people with Sickle Cell Disease.

MEMBERSHIP
rss feedemail usour twitterour facebook page linkdin youtubeinstagram
© 2024 European Sickle Cell Federation. All right reserved